Cargando…
Expression and clinical significance of SYNE1 and MAGI2 gene promoter methylation in gastric cancer
Gastric cancer is the fifth most common cancer and the third leading cause of cancer-related mortality globally. Abnormal DNA methylation is closely related to gastric cancer. The purpose of the study was to investigate the methylation of the SYNE1 and MAGI2 gene promoter and its relationship with t...
Autores principales: | Qu, Yanjun, Gao, Na, Wu, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850698/ https://www.ncbi.nlm.nih.gov/pubmed/33530176 http://dx.doi.org/10.1097/MD.0000000000023788 |
Ejemplares similares
-
Clinical effect of DAPK promoter methylation in gastric cancer: A systematic meta-analysis
por: Jia, Wenzhuo, et al.
Publicado: (2016) -
Clinical significance of serum neuron-specific enolase in gastric adenocarcinoma
por: Luo, Hai, et al.
Publicado: (2020) -
Expression and clinical significance of BDH1 in liver cancer
por: Liu, Zhicheng, et al.
Publicado: (2021) -
Promoter hypermethylation of MGMT gene may contribute to the pathogenesis of gastric cancer: A PRISMA-compliant meta-analysis
por: Zhang, Zongxin, et al.
Publicado: (2017) -
Quantitative assessment of the relationship between RASSF1A gene promoter methylation and bladder cancer (PRISMA)
por: Zhan, Leyun, et al.
Publicado: (2017)